By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Auspex Pharmaceuticals 

1261 Liberty Way
Suite C
Vista  California  92081-8356  U.S.A.
Phone: 760-599-1800 Fax: 760-599-1801



Company News
Auspex Pharmaceuticals (ASPX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/29/2015 7:42:55 AM
Auspex Pharmaceuticals (ASPX) Announces Pricing Of Follow On Offering 1/23/2015 7:19:53 AM
Auspex Pharmaceuticals (ASPX) Announces Proposed Public Offering Of Common Stock 1/22/2015 7:34:55 AM
Auspex Pharmaceuticals (ASPX) Receives FDA Orphan Drug Designation Of SD-809 For Treatment Of Tourette Syndrome In The Pediatric Population 1/15/2015 7:04:55 AM
Auspex Pharmaceuticals (ASPX) Announces SD-1077 Program For The Potential Treatment Of Parkinson's Disease And Related Movement Disorders 1/12/2015 7:34:41 AM
Auspex Pharmaceuticals (ASPX) Announces Favorable Topline Results From Thorough QT Clinical Trial Of SD-809 1/12/2015 6:59:58 AM
Auspex Pharmaceuticals (ASPX) To Present At The J.P. Morgan Healthcare Conference 1/6/2015 9:48:24 AM
Auspex Pharmaceuticals (ASPX) Added To The NASDAQ Biotechnology Index 12/23/2014 7:54:33 AM
SoCal's Auspex Pharmaceuticals (ASPX) Soars 90% On Huntington's Disease Drug Trial Data 12/17/2014 6:35:46 AM
Auspex Pharmaceuticals To Present At The Piper Jaffray Healthcare Conference 12/4/2014 3:45:40 PM